New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;COV;INTC;BSX;VRTX;JNJ From The Last 14 Days
Check below for free stories on MDT;COV;INTC;BSX;VRTX;JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
July 31, 2014
11:21 EDTINTCIntel may find difficulty shipping 40M tablet CPUs in 2014, DigiTimes says
Subscribe for More Information
10:35 EDTJNJJohnson & Johnson should get new Zytiga patent shortly, says Wells Fargo
Subscribe for More Information
07:23 EDTJNJJ&J withdrawing laparoscopic power morcellators from market, AP says
Subscribe for More Information
July 30, 2014
17:34 EDTBSXVascular Solutions announces settlement of patent lawsuit with Boston Scientific
Vascular Solutions (VASC) announced that it has reached a settlement of its patent lawsuit with Boston Scientific Corporation (BSX) relating to patents in the area of coronary guide extension catheters. Vascular Solutions filed the original lawsuit in U.S. District Court for the District of Minnesota in May 2013, alleging that Boston Scientific infringed three patents owned by Vascular Solutions related to rapid exchange guide extension technology by manufacturing and selling its Guidezilla guide extension catheter. Boston Scientific filed a counterclaim in July 2013, alleging that Vascular Solutions infringed a patent owned by Boston Scientific related to rapid exchange guide extension technology by manufacturing and selling its GuideLiner guide extension catheter. As part of the settlement agreement, all litigation between the two parties related to guide extension will be dismissed. The terms of the settlement are confidential.
07:50 EDTJNJSenate Judiciary Committee to hold a hearing
Subscribe for More Information
July 29, 2014
16:23 EDTVRTXVertex reports Q2 EPS (68c), consensus (72c)
Reports Q2 revenue $138M, consensus $132.06M.
15:53 EDTVRTXNotable companies reporting after market close
Subscribe for More Information
13:12 EDTINTCIntel working with cheap tablet makers in China, WantChinaTimes says
Subscribe for More Information
10:00 EDTBSXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:50 EDTJNJHarris & Harris invests in Accelerator Corporation
Subscribe for More Information
06:43 EDTBSXBoston Scientific initiated with a Neutral at Sterne Agee
Target $13.50.
July 28, 2014
13:20 EDTJNJPharmacyclics granted regular approval for Imbruvica
Subscribe for More Information
12:46 EDTMDTMedtronic receives FDA approval for PRESTIGE cervical disc system
Subscribe for More Information
12:26 EDTJNJPharmacyclics off lows, turns positive after FDA expands Imbruvica indication
Subscribe for More Information
12:24 EDTJNJFDA expands approved use of Imbruvica for chronic lymphocytic leukemia
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17, which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use. The FDA is also approving new labeling to reflect that Imbruvica’s clinical benefit in treating CLL has been verified. Imbruvica’s new use is being approved more than two months ahead of the product’s prescription drug user fee goal date of Oct. 7, the date the FDA was scheduled to complete review of the drug application. Imbruvica also received accelerated approval in November 2013 for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Clinical studies to verify and describe Imbruvica’s clinical benefit in mantle cell lymphoma are ongoing. Imbruvica is being jointly developed and commercialized in the United States by Pharmacyclics (PCYC) and Janssen Biotech (JNJ).
11:07 EDTMDT, BSXLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy, along with MEDACorp Specialist Arie Pieter Kappetein, MD, PhD and Bernhard Meier, MD, assess EU cardiology trends on an Analyst/Industry conference call to be held on July 31 at 3 pm.
07:30 EDTCOVQ1 Productions to hold a conference
Subscribe for More Information
06:52 EDTMDT, COVFormer official says Obama could limit inversion deals, NY Times reports
President Obama could limit tax inversion deals on his own authority, said Stephen Shay, former deputy assistant Treasury secretary for international tax affairs in the Obama administration, according to The New York Times. A 1969 law gives the president the ability to restrict inversion deals, said Shay, who also worked in the Reagan administration, the newspaper stated. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Alletgan (AGN). Reference Link
06:32 EDTJNJ, BSXJ&J dispute with Boston Scientific looks set to go to trial, NY Times says
Subscribe for More Information
06:17 EDTINTCStocks with implied volatility below IV index mean; INTC WMB
Subscribe for More Information
July 25, 2014
08:54 EDTJNJEMA issues positive opinion, recommends approval of Imbruvica
Subscribe for More Information
08:47 EDTINTCMellanox points to bigger than expected Grantley ramp, says Janney Capital
Subscribe for More Information
07:17 EDTJNJEMA recommends approval for Gilead, Janssen blood cancer drugs
Subscribe for More Information
06:30 EDTMDT, COVObama calls on Congress to end inversion deals, NY Times reports
Subscribe for More Information
06:17 EDTINTCIntel to launch Core M for use in notebook/tablet models in Q4, DigiTimes says
Subscribe for More Information
06:05 EDTCOVCovidien reports Q3 Surgical Solutions sales up 8% to $1.31B
Reports Q3 Vascular Therapies sales flat to $417M; Reports Q3 Respiratory and Patient Care sales up 2% to $966M.
06:03 EDTCOVCovidien reports Q3 adjusted EPS $1.04, consensus $1.00
Subscribe for More Information
05:59 EDTINTCStocks with implied volatility below IV index mean; INTC WMB
Stocks with implied volatility below IV index mean; Intel (INTC) 17, Williams (WMB) 22 according to iVolatility.
July 24, 2014
15:29 EDTCOVNotable companies reporting before tomorrow's open
Subscribe for More Information
14:35 EDTCOVObama to call for elimination of tax inversion deals, NY Times says
President Obama will call on Congress today to eliminate the tax inversion loophole, according to The New York Times. Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott’s (ABT), Medtronic's acquisition of Covidien (COV)and Valeant's (VRX) proposed takeover of Alletgan (AGN)Reference Link
10:56 EDTBSXStocks with call strike movement; NRG BSX
NRG Energy (NRG) January 35 call option implied volatility decreased 2% to 24, NRG Energy Boston Scientific (BSX) January 15 call option implied volatility decreased 2% to 25 according to IVolatility.
09:16 EDTJNJOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTJNJOrganovo enters 3D bio-printed tissue agreement with J&J unit
Organovo (ONVO) announced that it has entered into an agreement with Janssen Research and Development, a pharmaceutical company of Johnson & Johnson (JNJ), to evaluate the use of 3D bio-printed tissue in a drug discovery setting, outside of the company’s work in 3D liver tissue for toxicity testing. Terms were not disclosed.
08:28 EDTBSXBoston Scientific sees FY operating margin approaching 20%
Subscribe for More Information
08:19 EDTJNJ, MDTLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
07:04 EDTBSXBoston Scientific raises FY14 adjusted EPS to 79c-83c from 77c-82c
Subscribe for More Information
07:02 EDTBSXBoston Scientific sees Q3 adjusted EPS 18c-20c, consensus 19c
Subscribe for More Information
07:02 EDTBSXBoston Scientific reports Q2 Rhythm Management revenue growth of 7%
Subscribe for More Information
07:01 EDTBSXBoston Scientific reports Q2 adjusted EPS 21c, consensus 19c
Reports Q2 revenue $1.87B, consensus $1.87B
06:01 EDTINTCStocks with implied volatility below IV index mean; INTC SNDK
Subscribe for More Information
July 23, 2014
17:10 EDTBSXBoston Scientific receives CE Mark for Agent Drug Coated Balloon
Subscribe for More Information
15:30 EDTBSXNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Ford (F), consensus 36c; General Motors (GM), consensus 58c; Potash (POT), consensus 46c; Caterpillar (CAT), consensus $1.52; 3M (MMM), consensus $1.91; Union Pacific (UNP), consensus $1.43; Bristol-Myers Squibb (BMY), consensus 44c; Eli Lilly (LLY), consensus 65c; Celgene (CELG), consensus 89c; Precision Castparts (PCP), consensus $3.35; Raytheon (RTN), consensus $1.59; Noble Energy (NBL), consensus 79c; Hershey (HSY), consensus 76c; Southwest Airlines (LUV), consensus 61c; Boston Scientific (BSX), consensus 19c; JetBlue (JBLU), consensus 19c.
11:33 EDTINTCSamsung Ventures invests in BlueStacks, Business Insider reports
Subscribe for More Information
06:45 EDTCOVLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
06:01 EDTINTCStocks with implied volatility below IV index mean; INTC SHPG
Stocks with implied volatility below IV index mean; Intel (INTC) 18, Shire (SHPG) 19 according to iVolatility.
July 22, 2014
12:53 EDTINTCApplied Materials drops following report of opposition to merger
Subscribe for More Information
08:25 EDTBSXBoston Scientific risk/reward favorable into Q2 results, says RBC Capital
Subscribe for More Information
07:07 EDTCOVCovidien names Bryan Hanson as group president, effective October 1
Subscribe for More Information
05:59 EDTINTCStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
July 21, 2014
18:40 EDTJNJOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
17:03 EDTJNJJohnson & Johnson announces $5B share repurchase program
Johnson & Johnson announced that its board has approved the repurchase of up to $5B of the company's common stock. The company had approximately 2.82B shares of common stock outstanding as of June 29.
17:01 EDTJNJJohnson & Johnson announces $5B share repurchase program
16:38 EDTBSXBoston Scientific receives FDA approval for REBEL Platinum Stent system
Subscribe for More Information
12:41 EDTINTCIntel advances after analyst predicts mobile unit rebound coming
Shares of Intel (INTC) are advancing in a down market after Wells Fargo wrote that the company's mobile chip business could rebound significantly in coming quarters. WHAT'S NEW: Intel's mobile chip business could boost the company's growth and even enable it to beat earnings expectations, Wells Fargo wrote in a note to investors today. The chip maker's shipments of 4G modems should start rising significantly in the third quarter or fourth quarter of this year, the firm stated. The company has probably won some deals to provide LTE modems for smartphones and Samsung is likely one of the chip maker's initial customers, the firm wrote. Broadcom's (BRCM) decision to exit the baseband market probably improved Intel's position in the 4G market, Wells Fargo contended. Meanwhile, Intel said that by this year's holiday season, it should be ready to launch chips for mobile devices that are smaller than those of a key competitor, TSMC (TSM), Wells noted. Sales generated by Intel's mobile and communications unit may have bottomed last quarter or could do so during the current quarter, the firm believes. The unit's operating losses are likely to drop throughout this year, before falling sharply in the quarter ended March 2015, Wells estimated. The unit may approach break even by the end of 2015, the firm added. Wells kept an Outperform rating on the stock. WHAT'S NOTABLE: On July 15, Intel reported stronger than expected results for its quarter ended in June. PRICE ACTION: In early afternoon trading, Intel rose 43c, or 1.3%, to $34.13.
08:16 EDTMDT, COVDeutsche Bank analysts hold an analyst/industry conference call
Subscribe for More Information
07:34 EDTINTCIntel mobile business could be source of growth, says Wells Fargo
Wells Fargo believes that Intel's Mobile & Communications segment could be an important growth and profit driver for the company starting next year. The firm thinks the company's manufacturing technology lead and efforts to establish a foundry business could boost its Mobile & Communications segment. It keeps an Outperform rating on the stock.
07:15 EDTINTCO'Reilly to hold a conference
Subscribe for More Information
06:14 EDTINTCStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
July 18, 2014
16:47 EDTINTCMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
12:51 EDTMDT, COVKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
12:36 EDTINTCPlug Power said to be on list of companies probed by SEC, Probes Reporter says
Subscribe for More Information
11:42 EDTINTCAMD plummets after profit miss, analyst downgrades
Subscribe for More Information
11:34 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
06:06 EDTINTCStocks with implied volatility below IV index mean; LULU INTC
Subscribe for More Information
July 17, 2014
18:31 EDTINTCOn The Fly: After Hours Movers
Subscribe for More Information
14:54 EDTJNJJohnson & Johnson weakness creates buying opportunity, says Argus
Subscribe for More Information
11:23 EDTCOVOptions with increasing implied volatility
Subscribe for More Information
10:56 EDTJNJJohnson & Johnson reports 18% passive stake in Minerva
Subscribe for More Information
10:00 EDTCOVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 21st Century Fox (FOXA) downgraded to Buy from Strong Buy at ISI Group... Charter (CHTR) downgraded to Hold from Buy at Jefferies... Covidien (COV) downgraded to Hold from Buy at Needham... Diageo (DEO) downgraded to Underweight from Neutral at JPMorgan... GNC Holdings (GNC) downgraded to Hold from Buy at Jefferies... International Game (IGT) downgraded to Market Perform from Outperform at BMO Capital... JAVELIN Mortgage (JMI) downgraded to Market Perform from Outperform at JMP Securities... Macquarie Group (MQBKY) downgraded to Underweight from Neutral at JPMorgan... PNC Financial (PNC) downgraded to Neutral from Buy at Compass Point... PetSmart (PETM) downgraded to Sector Perform from Outperform at RBC Capital... Rexam (REXMY) downgraded to Hold from Buy at Deutsche Bank.
09:40 EDTINTCActive equity options trading on open
Subscribe for More Information
07:51 EDTINTCSenate Finance Committee to hold a hearing
The Committee holds a hearing entitled, "The Role of Trade & Technology in 21st Century Manufacturing" with Vice President Sturm of Intel on July 17 at 10 am. Webcast Link
06:41 EDTCOVCovidien downgraded to Hold from Buy at Needham
Subscribe for More Information
05:56 EDTINTCStocks with implied volatility below IV index mean; LULU INTC
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use